Abstract
Recent studies indicated that andrographolide was a potential anti-HIV therapeutic agent. In the paper, the synthesis of a series of andrographolide derivatives was described and their anti-HIV activities were evaluated in vitro. As compared with TI, compounds 5c, 5d and 5i showed moderate inhibitory activities on the cytopathic effect with TI above 10. Among the derivatives, compound 5i was the best one with TI > 51.
Keywords: Andrographolide, anti-HIV, derivatives, synthesis, cytopathic effect, HIV/AIDS, alkaloids, polysaccharides, flavonoids, triterpenes, lactones, sapon-ins, Andrographis paniculata, protein-mediated syncytia, HL60 cells, CD4+ lymphocyte level, HIV-1 RNA, lipopoly-saccharides (LPS)-induced tumor necrosis factor, interleukin-6, cyclooxygenase-2, acid anhydride, DMAP, CH2Cl2, propionic anhydride, hexanoic anhydride, benzoyl chloride, triphenylchloromethane, methylmorpholine, dicyclohexylcarbodiimide, C8166 cells, therapeutic index, anti-HIV-1 effects, hin-layer chromatography, DMSO, fetal bovine serum, 96-well microtiter plate, HIV-1 tissue culture infections dose
Medicinal Chemistry
Title: Synthesis and Preliminary Anti-HIV Activities of Andrographolide Derivatives
Volume: 6 Issue: 4
Author(s): Bin Wang, Liang Ge, Wenlong Huang, Huibin Zhang, Hai Qian, Jing Li and Yongtang Zheng
Affiliation:
Keywords: Andrographolide, anti-HIV, derivatives, synthesis, cytopathic effect, HIV/AIDS, alkaloids, polysaccharides, flavonoids, triterpenes, lactones, sapon-ins, Andrographis paniculata, protein-mediated syncytia, HL60 cells, CD4+ lymphocyte level, HIV-1 RNA, lipopoly-saccharides (LPS)-induced tumor necrosis factor, interleukin-6, cyclooxygenase-2, acid anhydride, DMAP, CH2Cl2, propionic anhydride, hexanoic anhydride, benzoyl chloride, triphenylchloromethane, methylmorpholine, dicyclohexylcarbodiimide, C8166 cells, therapeutic index, anti-HIV-1 effects, hin-layer chromatography, DMSO, fetal bovine serum, 96-well microtiter plate, HIV-1 tissue culture infections dose
Abstract: Recent studies indicated that andrographolide was a potential anti-HIV therapeutic agent. In the paper, the synthesis of a series of andrographolide derivatives was described and their anti-HIV activities were evaluated in vitro. As compared with TI, compounds 5c, 5d and 5i showed moderate inhibitory activities on the cytopathic effect with TI above 10. Among the derivatives, compound 5i was the best one with TI > 51.
Export Options
About this article
Cite this article as:
Wang Bin, Ge Liang, Huang Wenlong, Zhang Huibin, Qian Hai, Li Jing and Zheng Yongtang, Synthesis and Preliminary Anti-HIV Activities of Andrographolide Derivatives, Medicinal Chemistry 2010; 6 (4) . https://dx.doi.org/10.2174/1573406411006040252
DOI https://dx.doi.org/10.2174/1573406411006040252 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cutaneous Melanoma: A Test Field for Immunotherapy and a Medical Challenge
Current Cancer Therapy Reviews Viral Product Trafficking to Mitochondria, Mechanisms and Roles in Pathogenesis
Infectious Disorders - Drug Targets Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery
Anti-Cancer Agents in Medicinal Chemistry Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Damage and Recovery of the Bone Marrow Microenvironment Induced by Cancer Chemotherapy – Potential Regulatory Role of Chemokine CXCL12/Receptor CXCR4 Signalling
Current Molecular Medicine Non Polymeric Nanoparticles for Photodynamic Therapy Applications: Recent Developments
Current Medicinal Chemistry Fumagillin and Structurally Related Molecules as Source of New Drugs
Mini-Reviews in Organic Chemistry Novel Target Sites for Drug Screening: A Special Reference to Cancer, Rheumatoid Arthritis and Parkinson’s Disease
Current Signal Transduction Therapy Regulation of Cell Death and Survival by Resveratrol: Implications for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Potential Novel Targets in Breast Cancer
Current Pharmaceutical Biotechnology Apoptosis in Sepsis: Mechanisms, Clinical Impact and Potential Therapeutic Targets
Current Pharmaceutical Design Thrombotic Microangiopathy and Occult Neoplasia
Cardiovascular & Hematological Disorders-Drug Targets NK Cell Receptors and Their Interactions with MHC
Current Pharmaceutical Design In Vitro Regulatory Effect of Epididymal Serpin CRES on Protease Activity of Proprotein Convertase PC4/PCSK4
Current Molecular Medicine An Update on MDMX and Dual MDM2/X Inhibitors
Current Topics in Medicinal Chemistry Structural Biology Insight for the Design of Sub-type Selective Aurora Kinase Inhibitors
Current Cancer Drug Targets Challenges in the Design of Clinically Useful Brain-targeted Drug Nanocarriers
Current Medicinal Chemistry Relevance of the Deletion Polymorphisms of the Glutathione S-Transferases GSTT1 and GSTM1 in Pharmacology and Toxicology
Current Drug Metabolism Therapeutic Nucleic Acids
Recent Patents on Regenerative Medicine A Case of Subcutaneous Phaeohyphomycosis Associated with Leprosy
Infectious Disorders - Drug Targets